Recombinant Rhesus Macaque RPA2 Protein Pre-coupled Magnetic Beads

• Cat.No.: RPA2-3776R-B
• Product Overview: The Recombnant protein was conjugated to magnetic beads. This ready-to-use, pre-coupled magnetic beads are in uniform particle size and narrow size distribution with large surface area, which is conducive to convenient and fast capture target molecules with high specificity and achieve magnetic separation. This product can be equipped with automation equipment for high-throughput operations.

Specification

• Source: HEK293
• Species: Rhesus Macaque
• Form: Solution
• Particle size: ~2 μm
• Beads Surface: Hydrophilic
• Capacity: > 200 pmol rabbit IgG/ mg beads
• Applications: Immunoassay, In vitro diagnostics, cell sorting, Immunoprecipitation/Co-precipitation, Protein/antibody separation and purification.
• Stability: Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions.
• Storage: 2-8℃. Do not to freeze thaw the Beads
• Concentration: 10mg beads/mL
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: RPA2 replication protein A2, 32kDa [ Macaca mulatta (Rhesus monkey) ]
• Official Symbol: RPA2
• Synonyms: RPA2; replication protein A 32 kDa subunit
• Gene ID: 716612
• mRNA Refseq: NM_001260634
• Protein Refseq: NP_001247563
• UniProt ID: F7EYD7

Reviews

12/21/2020

This commitment ensures that I have access to the most advanced and reliable protein available, enhancing the integrity and impact of my experiments.

03/30/2020

The RPA2 protein exhibits exceptional quality, making it an ideal choice to meet my experimental requirements.

07/19/2018

the manufacturer's customer-centric approach highlights their focus on ensuring my satisfaction.

Q&As

How might RPA2 be targeted for cancer therapy?

Targeting RPA2 with specific inhibitors could disrupt DNA repair mechanisms in cancer cells, rendering them more susceptible to treatments like chemotherapy or radiation therapy.

How does RPA2 contribute to the maintenance of telomeres?

RPA2 participates in the protection and maintenance of telomeres, the protective caps at the end of chromosomes, thereby contributing to cellular longevity and genomic stability.

Are there any known side effects or challenges associated with targeting RPA2 in therapy?

Targeting RPA2 in therapy may pose challenges, as its essential role in normal cellular processes raises concerns about potential side effects. Careful modulation is crucial.

Can RPA2 be targeted for therapeutic purposes beyond cancer treatment?

Yes, exploring RPA2 as a therapeutic target extends to conditions where genomic stability is compromised, such as certain genetic disorders and autoimmune diseases.

Are there any ongoing clinical trials involving RPA2 in cancer treatment?

Information about specific clinical trials should be checked, but the potential use of RPA2 as a target for cancer therapy is an area of active research.